Slide 1Prostate Cancer An Update Mohamed Abdulla (M.D.) Prof. of Clinical Oncology Kasr El-Aini School of Medicine Cairo University Khartoum, 05/12/2009 Slide 2 Challenging…

Slide 1 Clinical Observation of Montelukast as a Partner Agent for Complementary Therapy Slide 2 Study Objectives To compare the clinical benefits of adding montelukast to…

Slide 1 Dyslipidemia/Lipid management in Diabetes Slide 2 M ECHANISMS R ELATING I NSULIN R ESISTANCE AND D YSLIPIDEMIA  TG  Apo B  VLDL (hepatic lipase) Kidney (CETP)CEHDL…

Slide 1 Alexander GG Turpie On behalf of Kenneth A Bauer, Scott D Berkowitz, Fred D Cushner, Bruce L Davidson, Michael Gent, Louis M Kwong, Michael R Lassen, Paul A Lotke,…

Slide 1 INTERESTING QUESTIONS & “UNDOING” EXPONENTS: LOGS Hey, hey logarithm…When we get the blues Slide 2 Recap Last week we looked at RATIONAL exponents and saw…

Slide 1 Logarithms: “undoing” exponents Slide 2 Recap Last week we looked at RATIONAL exponents and saw that A square root is the same as an exponent of ½ A cubed root…

Slide 1 Section 7.1 Graph Exponential Growth Functions Slide 2 Exponential functions are of the form y = ab x Example: when a > 0 and the b is greater than 1, the graph…

AHA 2008 Clinical Trial Summary Slides APPROACH Change in percent atheroma volume: -0.21% with rosiglitazone vs. 0.43% with glipizide (p = 0.12) Change in total atheroma…

AHA 2008 Clinical Trial Summary Slides APPROACH Change in percent atheroma volume: -0.21% with rosiglitazone vs. 0.43% with glipizide (p = 0.12) Change in total atheroma…

A Randomized Trial to Reduce Problematic Use of Amphetamine Type Stimulants Robert Tait, Rebecca McKetin, Frances Kay-Lambkin, Bradley Carron-Arthur, Anthony Bennett, Kylie…